↓ Skip to main content

The aftermath of the Merck's HIV vaccine trial

Overview of attention for article published in Retrovirology, July 2008
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#29 of 1,144)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
4 news outlets
twitter
14 X users
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The aftermath of the Merck's HIV vaccine trial
Published in
Retrovirology, July 2008
DOI 10.1186/1742-4690-5-56
Pubmed ID
Authors

Enrico Iaccino, Marco Schiavone, Giuseppe Fiume, Ileana Quinto, Giuseppe Scala

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 9%
South Africa 1 3%
Unknown 30 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Student > Bachelor 5 15%
Student > Master 4 12%
Student > Ph. D. Student 4 12%
Professor > Associate Professor 3 9%
Other 5 15%
Unknown 7 21%
Readers by discipline Count As %
Medicine and Dentistry 6 18%
Agricultural and Biological Sciences 5 15%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 3 9%
Chemistry 3 9%
Other 7 21%
Unknown 7 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2022.
All research outputs
#921,039
of 24,972,357 outputs
Outputs from Retrovirology
#29
of 1,144 outputs
Outputs of similar age
#1,845
of 92,579 outputs
Outputs of similar age from Retrovirology
#1
of 7 outputs
Altmetric has tracked 24,972,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,144 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 92,579 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them